Crossmark

FLI and FIB-4 in diagnosing metabolic dysfunction-associated steatotic liver disease in primary care: High prevalence and risk of significant disease

Crossref DOI link: https://doi.org/10.1016/j.aohep.2024.101584

Published Print: 2025-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Álvares-da-Silva, Mário Reis

Vargas, Márcia da Silva

Rabie, Soheyla Mohd Souza

Jonko, Gabriella

Riedel, Patricia Gabriela

Longo, Larisse

Gonçalves, Marcelo Rodrigues

Luft, Vivian Cristine

Joveleviths, Dvora
Funding

Funding for this research was provided by:

Fundação Instituto de Pesquisas Econômicas

Hospital de Clinicas de Porto Alegre (2019-0140)

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
License Information

Text and Data Mining valid from 2025-01-01

Text and Data Mining valid from 2025-01-01

Version of Record valid from 2024-09-10
More Information

This article is maintained by: Elsevier

Article Title: FLI and FIB-4 in diagnosing metabolic dysfunction-associated steatotic liver disease in primary care: High prevalence and risk of significant disease

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2024.101584

Content Type: article

Copyright: © 2024 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.